Dendreon's Other Investors

Dendreon raised a round of funding on , .

Dendreon is a biopharmaceutical company targeting cancer through the discovery, development, commercialization, and manufacturing of novel therapeutics. Its product Provenge is an autologous cellular …

Articles about Dendreon's Other Investors: